A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers

Clinical trial NCT04761744 · UNKNOWN

Trial details

NCT number: NCT04761744
Sponsor: Korean Cancer Study Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

DDR Gene Mutation Metastatic Solid Tumor

Start date: 2019-06-14
Primary completion: 2021-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.